南科大医学院
官方公众号
Wang Yukun, male, professor, PhD supervisor.Born in 1965 in qiqihar.In 1983, he was admitted to the fourth military medical university as a six-year clinical medicine (military medicine) undergraduate major.Currently, he is a member of the standing committee of the national pharmaceutical education special committee, vice chairman of the all-j pharmaceutical education special committee, member of the standing committee of the provincial pharmaceutical association and vice chairman of pharmaceutical management specialty, member of the standing committee of shenzhen pharmaceutical association, etc.Training 10 graduate students, teaching a number of undergraduate and graduate courses.It has been funded by more than 10 projects including J, C, H, ministry of health, Ministry of Education and provincial level.In the past five years, he has published more than 20 articles, including more than 10 SCI papers, won one first prize of China higher education association, one second prize of provincial teaching achievements, edited one textbook of science press, two other books and two textbooks of medical science and technology press.Direction: pharmaceutical application and pharmaceutical basis of health statistics, relationship between mRNA methylation and tumor genesis, and mechanism of tumor drug resistance.
Pharmaceutical application and pharmaceutical basis of health statistics
Relationship between mRNA methylation and tumor genesis
Mechanism of tumor drug resistance
1983-1989 Received a bachelor's degree in clinical medicine from Air Force Medical University of PLA (the Fourth Military Medical University)
1996-1999 Received a master's degree in social medicine and health management from Air Force Medical University of PLA (the Fourth Military Medical University)
2002-2005 Received a Ph.D. in Epidemiology and Health Statistics from Air Force Medical University of PLA (the Fourth Military Medical University)
2009.1-6 Having studied at Hasselt University, Belgium
2012.7-12 visited at the University of Wyoming
2014.8-12 Visited at Wolverhampton University
1990-1994 Assistant of Air Force Medical University of PLA (the Fourth Military Medical University)
1995-2000 lecturer of Air Force Medical University of PLA (the Fourth Military Medical University)
2001-2006 Associate Professor of Air Force Medical University of PLA (the Fourth Military Medical University) Graduate School
2006-2008 Associate Professor, Master Instructor of Air Force Medical University of PLA (the Fourth Military Medical University) Graduate School
2008-2018 Dean, Professor, Doctoral Supervisor of Air Force Medical University of PLA (the Fourth Military Medical University) Pharmacy School
2018.7 Professor, Ph.D. Faculty of Medicine, Southern University of Science and Technology
2018.7 Vice President, Hospital of Southern University of Science and Technology
Rongli has a third-class merit, and has won many outstanding awards such as outstanding party members, advanced teaching individuals, advanced individuals in postgraduate education, advanced individuals in the provincial “211” project, advanced individuals in provincial postgraduate education, and awards.
"The Discipline Construction of Colleges and Universities", the first prize of the 8th Outstanding Higher Education Research Achievements of the Chinese Higher Education Society in 2013, one of the main accomplishers
"Exploration and Practice of Teaching Reform of Pharmacology Network Course", second prize of Shaanxi Province Teaching Achievements in 2012, ranked third
"Building a new mode of chemistry teaching in higher medical colleges with organic integration of chemistry and medical knowledge", second prize of teaching achievements in Shaanxi Province in 2014, ranking second
"Construction of Pharmacy Case Library and Case Teaching Model Research", first prize of 2015 school-level teaching achievements, ranked second
Member of the Standing Committee of the Pharmaceutical Professional Committee of the People's Republic of China
Member of the Expert Group on Teaching Certification for Pharmaceutical Undergraduate Education in the People's Republic of China
Deputy Chairman of the Special Committee on Education and Pharmacy of the 8th and 9th Pharmacy Committee of the Chinese People's Liberation Army
Shaanxi Provincial Pharmaceutical Association Executive Director
Deputy Director of the Pharmaceutical Committee of the Pharmaceutical Association of Shaanxi Province
Shenzhen Pharmaceutical Association Executive Director
Deputy Director of the Expert Committee of the 13th Five-Year Plan Textbook (Pharmaceuticals) of General Higher Medical Colleges
Bao Han , Guo Chun-Guang, Qiu Peng-Cheng , Zhang Xin-Lei, Dong Qi, Wang Yu-Kun*. Long non-coding RNA Igf2as controls hepatocellular carcinoma progression through the ERK/MAPK signaling pathway.[J] .Oncology Letter, 2017, 14(3): 2831-2837.
jiaping Wang，Juncheng Jin,Fumei Li,Baohong Li*,Jianqiang Liu,Jie Jin,Chunfeng Wang,ZengyongQing* and Yukun Wang*. Combined experimental and theoretical insight into the drug delivery of nanoporous metal-organic frameworks. RSC Advangces, 05.85606.
Wang H B, Wang J, Yang Q, Zhang X W, Gao P, Xu S L, Sun X L*, Wang Y K*. Synthesis of a Novel Nitronyl Nitroxide Radical and Determination of its Protective Effects Against Infrasound-Induced Injury[J]. NEUROCHEMICAL RESEARCH. 2015, 40(7): 1526-1536.
Hou Z, Zhou Y, Li J, Zhang X, Shi X, Xue X, Li Z, Ma B, Wang Y, Li M, Luo X. Selective in vivo and in vitro activities of 3,3'-4-nitrobenzylidene-bis-4-hydroxycoumarin against methicillin-resistant Staphylococcus aureus by inhibition of DNA polymerase III. Sci Rep. 2015 Sep 1;5:13637.
Huang T, Zhang K, Sun L, Xue X, Zhang C, Shu Z, Mu N, Gu J, Zhang W, Wang Y. Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro.[J]. Drug Des Devel Ther. 2015, 9: 2485-2499.
Meng J, Da F, Ma X, Wang N, Wang Y, Zhang H, Li M, Zhou Y, Xue X, Hou Z, Jia M, Luo X. Antisense growth inhibition of methicillin-resistant Staphylococcus aureus by locked nucleic acid conjugated with cell-penetrating peptide as a novel FtsZ inhibitor[J]. Antimicrob Agents Chemother. 2015, 59(2): 914-922.
Li Z P, Li J, Qu D, Hou Z, Yang X H, Zhang Z D, Wang Y K, Luo X X, Li M K. Synthesis and pharmacological evaluations of 4-hydroxycoumarin derivatives as a new class of anti-Staphylococcus aureus agents[J]. JOURNAL OF PHARMACY AND PHARMACOLOGY. 2015, 67(4): 573-582.
Zhang F, Zhang X, Meng J, Zhao Y, Liu X, Liu Y, Wang Y, Li Y, Sun Y, Wang Z, Mei Q, Zhang T. ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer[J]. Oncotarget. 2015, 6(18): 16239-16252.
Su H C, Wu Z L, Wang Y K, Jiang Y H, Qiang S Y, Cheng H, Liu W C, Zhang J. An improved fluorescence polarization assay in 5'-nuclease reaction for gene promoter methylation detection[J]. JOURNAL OF BIOTECHNOLOGY. 2015, 211: 81-86.
王伟,任亚男,包晗,邱鹏程,张鑫磊,祁永飞,颜真,王玉琨*.我国基本药物可及性研究的Meta分析[J].中国药房,2018,29(15):2131-2134.
祁永飞,包晗,王玉琨*.中成药质量监管问题和原因分析及对策探讨[J].中国医药工业杂志,2018,49(01):119-123.
秦向阳, 张昱昊, 王宝龙, 邓晓军, 高鹏, 黄雁茹, 王玉琨*. 5-磺基水杨酸合铁(Ⅲ)配合物的组成及其稳定常数测定实验的教学方式改革[J]. 化学教育, 2017,38(6): 50-54.
祁永飞,包晗,邱鹏程,张鑫磊,王伟,王玉琨*. 2011-2015年我国药品监管统计年报分析[J]. 中国药房,2017,28(22):3135-3138.
包晗，邱鹏程，张鑫磊，王玉琨*. 市场互动一体化系统在药品生产流程信息化管理中的应用[J].中国药房，2017，28(25)：3461-3463.
王伟,祁永飞, 包晗, 邱鹏程, 张鑫磊, 王玉琨*.基于医药大数据建立精准药学临床评估体系的思考[J].中国药事,2017,31(12):1478-1482.
任磊，任亚男，王伟，包晗，王玉琨*. 某儿童医院167例药品不良反应分析，中国药事，2019年11月第33卷第11期，1315-1319.
任亚男，包晗，王伟，任磊，王玉琨*. 我国部分省市药品短缺现状研究及相关建议，中国药事，2020年3月第34卷第3期，275-282.
